HomeNDC LookupIngredients › Adalimumab
📦 NDC / package directory — not a drug information page

Adalimumab NDCs, Package Codes, Strengths & Labelers

This page lists NDC package records for Adalimumab products — strengths, dosage forms, package sizes, labelers, 11-digit billing NDCs, pricing data when available, and links to each individual NDC page. It’s an NDC/package & billing directory, not a clinical drug page.

Key stats

50
Package NDCs
39
Products
39
Active listings
0
Discontinued
12
Labelers
18
Strengths
4
Dosage forms
9
With NADAC pricing

By strength, form & labeler

NDC products by strength
ADALIMUMAB 40 mg/.8mL 2
ADALIMUMAB-FKJP 40 mg/.8mL 2
ADALIMUMAB-BWWD 50 mg/mL 2
ADALIMUMAB-BWWD 100 mg/mL 2
ADALIMUMAB 80 mg/.8mL 1
ADALIMUMAB-ADBM 40 mg/.8mL 1
ADALIMUMAB-ADBM 10 mg/.2mL 1
ADALIMUMAB-ADBM 100 mg/mL 1
ADALIMUMAB (HUMIRA) 80 mg/mL 1
ADALIMUMAB-ADBM 50 mg/mL 1
By dosage form
KIT 17
LIQUID 11
INJECTION, SOLUTION 7
INJECTION 4
Top labelers
AbbVie Inc. 13
Boehringer Ingelheim Fremont, Inc. 6
Cordavis Limited 5
Terumo Corporation 3
Novo Nordisk Production Belgium SA 3
Fresenius Kabi USA, LLC 2
SAMSUNG BIOLOGICS Co., Ltd. 2
Wyeth BioPharma Division of Wyeth... 1

Browse records — 39 products

Drug / product Billing NDC NADAC / unit Status
adalimumab 40 mg/.8mL INJECTION, SOLUTION Catalent · NDC 61434-0020-00 · 1440 SYRINGE in 1 CASE (61434-020-00) / .8 mL in 1 SYRINGE 61434-0020-00 On market View →
adalimumab 80 mg/.8mL INJECTION, SOLUTION AbbVie · NDC 00074-1117-00 · .8 mL in 1 SYRINGE (0074-1117-00) 00074-1117-00 On market View →
Adalimumab 40 mg/.8mL LIQUID Boehringer · NDC 83012-0009-10 · 1 mL in 1 SYRINGE (83012-009-10) 83012-0009-10 On market View →
Adalimumab 10 mg/.2mL LIQUID Boehringer · NDC 83012-0013-10 · 1 mL in 1 SYRINGE (83012-013-10) 83012-0013-10 On market View →
Adalimumab 100 mg/mL LIQUID Boehringer · NDC 83012-0046-99 · 20000 mL in 1 BAG (83012-046-99) 83012-0046-99 On market View →
Adalimumab 80 mg/mL LIQUID Lonza · NDC 69438-0009-02 · 2000 mL in 1 BOTTLE (69438-0009-2) 69438-0009-02 On market View →
Adalimumab 50 mg/mL LIQUID Boehringer · NDC 83012-0045-99 · 20000 mL in 1 BAG (83012-045-99) 83012-0045-99 On market View →
adalimumab 40 mg/.8mL INJECTION, SOLUTION AbbVie · NDC 00074-2330-00 · .4 mL in 1 SYRINGE (0074-2330-00) 00074-2330-00 On market View →
ADALIMUMAB 40 mg/.8mL INJECTION, SOLUTION Terumo · NDC 53877-0801-01 · 144 SYRINGE in 1 BOX (53877-801-01) / .8 mL in 1 SYRINGE 53877-0801-01 On market View →
Adalimumab 2 kg/2kg LIQUID SAMSUNG · NDC 71124-0027-00 · 2 kg in 1 BOTTLE, PLASTIC (71124-0027-0) 71124-0027-00 On market View →
Adalimumab 50 mg/mL INJECTION Novo · NDC 43835-0036-01 · 15 BOX in 1 CONTAINER (43835-0036-1) / 160 SYRINGE in 1 BOX / .8 mL in 1 SYRINGE 43835-0036-01 On market View →
Adalimumab 6 kg/6kg LIQUID SAMSUNG · NDC 71124-0023-00 · 6 kg in 1 BAG (71124-0023-0) 71124-0023-00 On market View →
Adalimumab 100 mg/mL INJECTION Novo · NDC 43835-0035-01 · 224 SYRINGE in 1 BOX (43835-0035-1) / .4 mL in 1 SYRINGE 43835-0035-01 On market View →
ADALIMUMAB 20 mg/.4mL INJECTION, SOLUTION Terumo · NDC 53877-0803-01 · 180 SYRINGE in 1 BOX (53877-803-01) / .4 mL in 1 SYRINGE 53877-0803-01 On market View →
ADALIMUMAB 40 mg/.8mL INJECTION, SOLUTION Terumo · NDC 53877-0802-01 · 180 SYRINGE in 1 BOX (53877-802-01) / .8 mL in 1 SYRINGE 53877-0802-01 On market View →
Adalimumab 20 mg/.4mL LIQUID Boehringer · NDC 83012-0012-10 · 1 mL in 1 SYRINGE (83012-012-10) 83012-0012-10 On market View →
adalimumab 40 mg/.4mL INJECTION, SOLUTION AbbVie · NDC 00074-1115-00 · .4 mL in 1 SYRINGE (0074-1115-00) 00074-1115-00 On market View →
adalimumab 50 mg/mL INJECTION Samsung · NDC 71124-0059-00 · .8 mL in 1 VIAL, GLASS (71124-0059-0) 71124-0059-00 On market View →
Adalimumab 40 mg/.4mL LIQUID Boehringer · NDC 83012-0011-10 · 1 mL in 1 SYRINGE (83012-011-10) 83012-0011-10 On market View →
Adalimumab 1 g/g LIQUID AbbVie · NDC 00074-1867-99 · 2000 g in 1 BOTTLE (0074-1867-99) 00074-1867-99 On market View →
Adalimumab 100 mg/mL INJECTION Novo · NDC 43835-0033-01 · 9 BOX in 1 CONTAINER (43835-0033-1) / 160 SYRINGE in 1 BOX / .4 mL in 1 SYRINGE 43835-0033-01 On market View →
Adalimumab 95.5 kg/95.5L LIQUID Wyeth · NDC 58394-0051-05 · 95.5 L in 1 CONTAINER (58394-051-05) 58394-0051-05 On market View →
Adalimumab-aacf KIT Fresenius · NDC 65219-0612-99 · 1 KIT in 1 CARTON (65219-612-99) * .8 mL in 1 SYRINGE, GLASS (65219-610-02) * 1 SWAB in 1 POUCH (65219-332-95) 65219-0612-99 $872.797 /unit · NADAC On market View →
Adalimumab-aacf KIT Fresenius · NDC 65219-0620-20 · 1 KIT in 1 CARTON (65219-620-20) * .8 mL in 1 SYRINGE, GLASS (65219-618-02) * 1 SWAB in 1 POUCH (65219-332-95) 65219-0620-20 On market View →
Humira Adalimumab KIT AbbVie · NDC 00074-0817-02 · 2 KIT in 1 CARTON (0074-0817-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .1 mL in 1 SYRINGE * 1 mL in 1 PACKET 00074-0817-02 On market View →
Humira Adalimumab KIT AbbVie · NDC 00074-0616-02 · 2 KIT in 1 CARTON (0074-0616-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .2 mL in 1 SYRINGE * 1 mL in 1 PACKET 00074-0616-02 $3,366.120 /unit · NADAC On market View →
Humira Adalimumab KIT Cordavis · NDC 83457-0124-02 · 2 KIT in 1 CARTON (83457-124-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (83457-123-01) / .8 mL in 1 SYRINGE * 1 mL in 1 PACKET (83457-927-01) 83457-0124-02 On market View →
Humira Adalimumab KIT AbbVie · NDC 00074-0124-01 · 1 KIT in 1 CARTON (0074-0124-01) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 1 mL in 1 PACKET 00074-0124-01 On market View →
Humira Adalimumab KIT AbbVie · NDC 00074-2540-01 · 1 KIT in 1 CARTON (0074-2540-01) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 1 mL in 1 PACKAGE 00074-2540-01 On market View →
HUMIRA Adalimumab KIT A-S · NDC 50090-4487-00 · 2 KIT in 1 CARTON (50090-4487-0) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 1 mL in 1 PACKET 50090-4487-00 On market View →
Where does this data come from?
NDC package records, strengths, forms and labelers come from the openFDA NDC Directory; pricing is CMS NADAC. Grouped by active-ingredient name. This is package/billing reference data, not clinical drug information.